Fitch Affirms Jazz’s IDR at ‘BB’; Outlook Stable

✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Pediatric EpilepsyCbdEpidiolexDrug AccessPharmaceutical Why This MattersJazz Pharmaceuticals develops Epidiolex (cannabidiol), the only FDA-approved cannabis-derived...

Read More